Panel Discussion: Demonstrating Opportunity in Renal to Support a Business Case:
Time: 9:30 am
day: Day One
Speakers:
Jyothis is an entrepreneurial physician-scientist with a track-record in global leadership. Leading clinical development of BI’s cardio-metabolic portfolio (which includes two blockbusters – Empagliflozin and Linagliptin) His global outcome-trial leadership includes the pragmatic trial EXSCEL, the active-comparator trial CAROLINA, the CARMELINA trial with a renal-enriched population and the EMPEROR Heart Failure Program. This decade-long experience…Read more
Uptal Patel, MD, Senior Director, Inflammation & Respiratory Therapeutics, Gilead Sciences. Dr. Patel attended medical school at UCSF and completed residency and fellowship training at the University of Michigan. He also received advanced training in health services research and epidemiology, and has been board certified in internal medicine, pediatrics, adult nephrology, and pediatric nephrology. He…Read more
